NASDAQ · AKU
Healthcare · Medical - Diagnostics & Research
$0.29
Down-$0.06 (-17.87%)
Updated Sep 11, 2026, 1:02 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AKU does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning AKU.
AKU research
Company profile and research snapshot.
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 14, 2022 | Canaccord Genuity | Speculative Buy | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Sep 14, 2023
Rekstrarniðurstaða A- og B-hluta Akureyrarbæjar fyrri hluta ársins 2023 var neikvæð um 1.196,8 milljónir króna en áætlun gerði ráð fyrir að rekstrarhalli yrði 1.802,4 milljónir króna á tímabilinu. Afkoma samstæðunnar fyrri hluta ársins var því nokkru betri en áætlun hafði gert ráð fyrir eða sem nemur 606 milljónum króna.
GlobeNewswire Inc. · Apr 13, 2023
Ársreikningar Akureyrarbæjar fyrir árið 2022 voru lagðir fram í bæjarráði í dag. Rekstur samstæðu Akureyrarbæjar gekk í meginatriðum vel og var betri en gert hafði verið ráð fyrir. Fjárhagsáætlun gerði ráð fyrir 893 milljóna króna halla en niðurstaðan var neikvæð um 671 milljón króna. Vaxandi verðbólga og lífeyrisskuldbindingar settu mark sitt á uppgjörið. Sjóðstreymið var betra en árið áður.
Zacks Investment Research · Sep 19, 2022
With the new facility in Naples, Encompass Health (EHC) now has 153 inpatient rehabilitation units in total.
GlobeNewswire Inc. · Sep 15, 2022
Rekstrarniðurstaða A- og B-hluta Akureyrarbæjar á fyrri hluta ársins 2022 var neikvæð um 1.138,7 milljónir króna en áætlun gerði ráð fyrir að rekstrarhalli yrði 1.227,8 milljónir króna á tímabilinu. Afkoma samstæðunnar á fyrri hluta ársins er því nokkru betri en áætlun gerði ráð fyrir eða sem nemur 89 milljónum króna.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AKU.
No results
No recent SID articles mention AKU.
